Akcea Therapeutics Inc Revenue per Employee (AKCA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Akcea Therapeutics Inc   (NASDAQ: AKCA)
 

Akcea Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Akcea Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,625,870, but the productivity of Akcea Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 9 other companies have achieved higher revenue per employee. While Akcea Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 307. Akcea Therapeutics Inc has 207 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKCA Revenue per Employee (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Revenue Change -15.95 % -90.19 % 2621.19 % 7.19 % 45.31 %
Sales per Employee (TTM) $ 1,625,870 1,646,382 2,360,111 1,068,889 1,062,208
AKCA's Total Ranking # 307 # 0 # 0 # 0 # 0
Seq. Revenue Change 39.21 % -94.21 % 1245.42 % -22.53 % -83.75 %

AKCA Company Profile >> Back to AKCA Efficiency Comparisons >> Compare AKCA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 10
Overall Market # 307

Revenue per Employee Statistics
High Average Low
$ 2,360,111 $ 1,877,454 $ 1,625,870
(Dec 31 2019)   (Jun 30 2020)



Financial Statements
Akcea Therapeutics Inc 's Revenue MRQ $ 22 Millions Visit AKCA's Income Statement
Akcea Therapeutics Inc 's Revenues TTM $ 337 Millions Visit AKCA's aggregate revenue growth
What are AKCA's Sales? Visit AKCA's Sales by Segment




Other Ratios
Akcea Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AKCA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AKCA's Competitors
Revenue per Employee for AKCA's Suppliers
Revenue per Employee for AKCA's Customers

You may also want to know
AKCA's Sales Growth Rates AKCA's Pe Price to earnings ratio AKCA's Receivables Turnover Ratio AKCA's Stock Quote
AKCA's Net Income Growth Rates AKCA's Ps Price to Sales ratio AKCA's Sales per Employee AKCA's Asset Turnover Ratio
AKCA's Net Margin AKCA's Pb Price to Book ratio AKCA's Financial Strength Ratios AKCA's Dividend Payout Ratio
Date modified: 2026-08-29T17:40:54+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2020, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2020Number of Employees Jun 30 2020
Ligand Pharmaceuticals Incorporated  2,689,191.49 $ 126.392  Million 47 
Illumina Inc   2,617,968.75 $ 3,351.000  Million 1,280 
Beam Therapeutics Inc   2,611,544.95 $ 1,334.499  Million 511 
Nektar Therapeutics  2,579,365.08 $ 162.500  Million 63 
Ernexa Therapeutics Inc   2,579,200.00 $ 12.896  Million 5 
Telesis Bio Inc   2,375,363.64 $ 26.129  Million 11 
Synlogic Inc   2,081,000.00 $ 2.081  Million 1 
Tvardi Therapeutics Inc   2,001,916.67 $ 24.023  Million 12 
Veru Inc   1,978,563.85 $ 39.571  Million 20 
Palvella Therapeutics Inc   1,962,379.31 $ 56.909  Million 29 
Biogen Inc   1,931,640.00 $ 14,487.300  Million 7,500 
Innoviva Inc   1,882,704.40 $ 299.350  Million 159 
Amgen Inc   1,869,307.69 $ 24,301.000  Million 13,000 
Exicure Inc   1,753,750.00 $ 14.030  Million 8 
Akebia Therapeutics Inc   1,753,360.82 $ 340.152  Million 194 
Aytu Biopharma Inc  1,727,005.00 $ 27.632  Million 16 
Lannett Company Inc  1,700,310.34 $ 197.236  Million 116 
Prestige Consumer Healthcare Inc   1,684,649.12 $ 960.250  Million 570 
Sunwin Stevia International Inc.  1,640,067.94 $ 26.241  Million 16 
Acorda Therapeutics Inc   1,567,990.20 $ 159.935  Million 102 
Kala Bio inc   1,511,666.67 $ 4.535  Million 3 
Eagle Pharmaceuticals inc   1,502,658.12 $ 175.811  Million 117 
Alexion Pharmaceuticals Inc   1,443,002.35 $ 5,536.800  Million 3,837 
Crispr Therapeutics Ag  1,438,532.34 $ 289.145  Million 201 
Scienture Holdings Inc   1,422,587.33 $ 12.803  Million 9 
Emergent Biosolutions Inc   1,399,333.33 $ 1,259.400  Million 900 
Surgalign Holdings Inc   1,352,100.53 $ 255.547  Million 189 
Puma Biotechnology Inc   1,346,776.54 $ 241.073  Million 179 
Gilead Sciences Inc   1,304,352.94 $ 22,174.000  Million 17,000 
Enanta Pharmaceuticals Inc  1,251,291.67 $ 150.155  Million 120 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.